Israeli Skin Care Firm Plans to Raise $75 Million in New York IPO

Foamix, based in Rehovot, files draft prospectus for offering that would value company at less than $200 million.

comments Print
Foamix, which is using a proprietary foam technology to develop topical treatments for acne, impetigo and other skin conditions, is planning to raise $75 million in an initial public offering in New York.